Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 2 Interventional

VBI-S for the Treatment of Hypotension in Hypovolemic Septic Shock Patients

ClinicalTrials.gov ID: NCT04257136

Public ClinicalTrials.gov record NCT04257136. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 8:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is being conducted to evaluate the safety and effectiveness of VBI-S in elevating the blood pressure of septic shock patients with absolute or relative hypovolemia.

Study identification

NCT ID
NCT04257136
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Vivacelle Bio
Industry
Enrollment
20 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 17, 2020 (Actual)
Primary completion
Dec 31, 2023 (Estimated)
Completion
Dec 31, 2023 (Estimated)
Last update posted
Oct 23, 2023

2020 – 2023

United States locations

U.S. sites
8
U.S. states
6
U.S. cities
8
Facility City State ZIP Site status
Dignity Health Chandler Arizona 85224 —
University of Arizona Tucson Arizona 85719 —
UMD Shock Trauma Baltimore Maryland 21201 —
Adventist Health Care Silver Spring Maryland 20904 —
Henry Ford Health System Detroit Michigan 48202 —
Truman Medical Center Kansas City Missouri 64108 —
Mount Sinai Hospital New York New York 10029 —
Einstine Medical Center East Norriton Pennsylvania 19403 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04257136, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 23, 2023 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04257136 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →